DRTSW
Alpha Tau Medical Ltd WT (DRTSW)
$
31About Alpha Tau Medical Ltd WT (DRTSW)
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.
Details
Daily high
$0.35
Daily low
$0.31
Price at open
$0.35
52 Week High
$0.50
52 Week Low
$0.09
Market cap
--
Dividend yield
0.00%
Volume
14,423
Avg. volume
40,498
P/E ratio
--
Alpha Tau Medical Ltd WT News
Details
Daily high
$0.35
Daily low
$0.31
Price at open
$0.35
52 Week High
$0.50
52 Week Low
$0.09
Market cap
--
Dividend yield
0.00%
Volume
14,423
Avg. volume
40,498
P/E ratio
--